CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- 4 Open-market sale President & COO sold 500,000 shares at $13.02 ($6,510,000)
- 4 Option exercise Pres&Chief Investment Officer acquired 27,790 shares (option exercise)
- 4 Other disposition CEO disposed of 10,243 shares (other)
- 4 Other disposition 10% owner disposed of 61,947 shares (other)
- 4 Other disposition Chief Accounting Officer disposed of 92 shares (other)
- 4 Other disposition President & COO disposed of 16,416 shares (other)
- 4 Other disposition Chief Accounting Officer disposed of 1,403 shares (other)
- 4 Other disposition CEO disposed of 11,227 shares (other)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 16 of 26 · 511 filings